Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract March 2012

Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS8535 in vivo

Barbara M. Wirostko; Hiroshi Umeno; Henry Hsu; Muralitharan Kengatharan

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5079.

ARVO Annual Meeting Abstract March 2012

Pharmaceutical Profile of a Novel Rho Kinase (ROCK) inhibitor ATS8535 for Reduction of IOP in Glaucoma

Muralitharan Kengatharan; Hiroshi Umeno; Barbara Wirostko; Henry Hsu

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5081.

ARVO Annual Meeting Abstract April 2011

Safety and Efficacy of a Novel Topical Rho Kinase Inhibitor ATS907 in Normotensive Cynomolgus Monkeys

Barbara M. Wirostko; H Umeno; Henry H. Hsu; Muralitharan Kengatharan

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3096.

ARVO Annual Meeting Abstract April 2011

Pharmaceutical Profile Of A Novel Rho Kinase (ROCK) Inhibitor ATS907 For Reduction Of IOP In Glaucoma

Muralitharan Kengatharan; Barbara M. Wirostko; H Umeno; Henry H. Hsu

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3106.

ARVO Annual Meeting Abstract April 2011

Tolerability and IOP Lowering Activity of a Topical Rho Kinase Inhibitor, ATS907, in Normotensive Rabbits

Henry H. Hsu; Muralitharan Kengatharan; H Umeno; Barbara M. Wirostko

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3109.

Retinal Cell Biology April 2008

Mecamylamine Suppresses Basal and Nicotine-Stimulated Choroidal Neovascularization

PDF

Katsuji Kiuchi; Masato Matsuoka; Jenny C. Wu; Raquel Lima e Silva; Muralitharan Kengatharan; Mary Verghese; Shinji Ueno; Katsutoshi Yokoi; Naw Htee Khu; John P. Cooke; Peter A. Campochiaro
TAGS: choroidal neovascularization, mecamylamine, nicotine, endothelial cells
Invest. Ophthalmol. Vis. Sci.. 2008; 49(4):1705-1711. https://doi.org/10.1167/iovs.07-0089

Advertisement